Skip to main content
Top
Gepubliceerd in: TPO - De Praktijk 5/2015

01-10-2015 | Farmacotherapie

Aanvalsbehandeling bij jicht

Auteurs: Kenny van Deventer, dr. Dick Bijl

Gepubliceerd in: TvPO | Uitgave 5/2015

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Jicht is een pijnlijke, aanvalsgewijs optredende artritis, meestal met een plotseling begin, vaak ’s nachts, met als belangrijke kenmerken een veel voorkomende typische gewrichtslokalisatie (het metatarsofalangeaal (MTP)-1-gewricht van de grote teen), een relatief korte aanvalsduur (enkele dagen tot twee à drie weken) en een recidiverend karakter.1
Literatuur
2.
go back to reference Schlesinger N. Management of acute and chronic gouty arthritis: present state-of-the-art. Drugs 2004;64:2399-2416.CrossRefPubMed Schlesinger N. Management of acute and chronic gouty arthritis: present state-of-the-art. Drugs 2004;64:2399-2416.CrossRefPubMed
3.
go back to reference Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008;58:26-35.PubMedCentralCrossRefPubMed Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008;58:26-35.PubMedCentralCrossRefPubMed
4.
go back to reference Shoji A, Yamanaka H, Kamatani N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum 2004;51:321-5.CrossRefPubMed Shoji A, Yamanaka H, Kamatani N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum 2004;51:321-5.CrossRefPubMed
5.
go back to reference Perez-Ruiz F, Calabozo M, Pijoan JI, Herrero-Beites AM, Ruibal A. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum 2002;47:356-60.CrossRefPubMed Perez-Ruiz F, Calabozo M, Pijoan JI, Herrero-Beites AM, Ruibal A. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum 2002;47:356-60.CrossRefPubMed
6.
go back to reference Jacobs JWG, Bijlsma JWJ. Jicht: de huidige visie op ontstaan, diagnostiek en therapie. Ned Tijdschr Geneeskd 1996;140:187-91.PubMed Jacobs JWG, Bijlsma JWJ. Jicht: de huidige visie op ontstaan, diagnostiek en therapie. Ned Tijdschr Geneeskd 1996;140:187-91.PubMed
7.
go back to reference Teng GG, Nair R, Saag KG. Pathophysiology, clinical presentation and treatment of gout. Drugs 2006;66:1547-63.CrossRefPubMed Teng GG, Nair R, Saag KG. Pathophysiology, clinical presentation and treatment of gout. Drugs 2006;66:1547-63.CrossRefPubMed
8.
go back to reference Martinon F. Mechanisms of uric acid crystal-mediated autoinflammation. Immunol Rev 2010;233:218-32.CrossRefPubMed Martinon F. Mechanisms of uric acid crystal-mediated autoinflammation. Immunol Rev 2010;233:218-32.CrossRefPubMed
9.
go back to reference Li EK. Gout: a review of its aetiology and treatment. Hong Kong Med J 2004;10:261-70. Li EK. Gout: a review of its aetiology and treatment. Hong Kong Med J 2004;10:261-70.
10.
go back to reference Ahern MJ, Reid C, Gordon TP, McCredie M, Brooks PM, Jones M. Does colchicine work? The results of the first controlled study in acute gout. Aust N Z J Med 1987;17:301-4.CrossRefPubMed Ahern MJ, Reid C, Gordon TP, McCredie M, Brooks PM, Jones M. Does colchicine work? The results of the first controlled study in acute gout. Aust N Z J Med 1987;17:301-4.CrossRefPubMed
11.
go back to reference Terkeltaub RA, Furst DE, Bennett K, Kook KA, Crockett RS, Davis MW. High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum 2010;62:1060-8.CrossRefPubMed Terkeltaub RA, Furst DE, Bennett K, Kook KA, Crockett RS, Davis MW. High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum 2010;62:1060-8.CrossRefPubMed
12.
go back to reference Informatorium Medicamentorum. Den Haag: KNMP, 2015. Informatorium Medicamentorum. Den Haag: KNMP, 2015.
13.
go back to reference Janssens HJ, Fransen J, Van de Lisdonk EH, Van Riel PL, Van Weel C, Janssen M. A diagnostic rule for acute gout arthritis in primary care without joint fluid analysis. Arch Intern Med 2010;170:1120-6.CrossRefPubMed Janssens HJ, Fransen J, Van de Lisdonk EH, Van Riel PL, Van Weel C, Janssen M. A diagnostic rule for acute gout arthritis in primary care without joint fluid analysis. Arch Intern Med 2010;170:1120-6.CrossRefPubMed
15.
go back to reference Antigout drugs. In: Sweetman SC (ed.). Martindale, the complete drug reference 36th edition. Londen: Pharmaceutical Press 2009:552-60. Antigout drugs. In: Sweetman SC (ed.). Martindale, the complete drug reference 36th edition. Londen: Pharmaceutical Press 2009:552-60.
16.
go back to reference Commentaren Medicatiebewaking. Houten: Health Base, 2015. Commentaren Medicatiebewaking. Houten: Health Base, 2015.
17.
go back to reference Martinon F. Mechanisms of uric acid crystal-mediated autoinflammation. Immunol Rev 2010;233:218-32.CrossRefPubMed Martinon F. Mechanisms of uric acid crystal-mediated autoinflammation. Immunol Rev 2010;233:218-32.CrossRefPubMed
18.
go back to reference Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 2005;353:1711-23.CrossRefPubMed Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 2005;353:1711-23.CrossRefPubMed
19.
go back to reference Man CY, Cheung IT, Cameron PA, Rainer TH. Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial. Ann Emerg Med 2007;49:670-7.CrossRefPubMed Man CY, Cheung IT, Cameron PA, Rainer TH. Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial. Ann Emerg Med 2007;49:670-7.CrossRefPubMed
20.
go back to reference Janssens HJ, Janssen M, Van de Lisdonk EH, Van Riel PL, Van Weel C. Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial. Lancet 2008;371:1854-60.CrossRefPubMed Janssens HJ, Janssen M, Van de Lisdonk EH, Van Riel PL, Van Weel C. Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial. Lancet 2008;371:1854-60.CrossRefPubMed
22.
go back to reference Corticosteroids. In: Sweetman SC (ed.). Martindale, the complete drug reference 36th edition. Londen: Pharmaceutical Press 2009:1490-1546. Corticosteroids. In: Sweetman SC (ed.). Martindale, the complete drug reference 36th edition. Londen: Pharmaceutical Press 2009:1490-1546.
23.
go back to reference Schumacher HR Jr, Boice JA, Daikh DI, Mukhopadhyay S, Malmstrom K, Ng J, et al. Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis. BMJ 2002;324:1488-92.PubMedCentralCrossRefPubMed Schumacher HR Jr, Boice JA, Daikh DI, Mukhopadhyay S, Malmstrom K, Ng J, et al. Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis. BMJ 2002;324:1488-92.PubMedCentralCrossRefPubMed
24.
go back to reference Rubin BR, Burton R, Navarra S, Antigua J, Londono J, Pryhuber KG, et al. Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial. Arthritis Rheum 2004;50:598-606.CrossRefPubMed Rubin BR, Burton R, Navarra S, Antigua J, Londono J, Pryhuber KG, et al. Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial. Arthritis Rheum 2004;50:598-606.CrossRefPubMed
25.
go back to reference Nonsteroidal anti-inflammatory drugs. In: Sweetman SC, editors. Martindale, the complete drug reference 36th edition. Londen: Pharmaceutical Press 2009:96-101. Nonsteroidal anti-inflammatory drugs. In: Sweetman SC, editors. Martindale, the complete drug reference 36th edition. Londen: Pharmaceutical Press 2009:96-101.
26.
go back to reference Biscarini L. Non-steroidal anti-inflammatory drugs. In Dukes MNG, Aronson JK, editors. Meyler’s side effects of drugs. Amsterdam: Elsevier, 2000, p. 246-309. Biscarini L. Non-steroidal anti-inflammatory drugs. In Dukes MNG, Aronson JK, editors. Meyler’s side effects of drugs. Amsterdam: Elsevier, 2000, p. 246-309.
Metagegevens
Titel
Aanvalsbehandeling bij jicht
Auteurs
Kenny van Deventer
dr. Dick Bijl
Publicatiedatum
01-10-2015
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
TvPO / Uitgave 5/2015
Print ISSN: 2666-9838
Elektronisch ISSN: 2666-9846
DOI
https://doi.org/10.1007/s12503-015-0084-x

Andere artikelen Uitgave 5/2015

TPO - De Praktijk 5/2015 Naar de uitgave

Weet je dit?

Vragen